860807 | CP-LC-1254
2-hexyldecyl 2-((2-(dimethylamino)ethyl)carbamoyl)-4-((3-((2-hexyldecyl)oxy)-3-oxopropyl)thio)butanoate

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
CP-LC-1254
2-hexyldecyl 2-((2-(dimethylamino)ethyl)carbamoyl)-4-((3-((2-hexyldecyl)oxy)-3-oxopropyl)thio)butanoate
Manufactured and Distributed under License from Certest Biotec S.L
CP-LC-1254 is an ionizable lipid that successfully encapsulates mRNA. In vivo studies carried out in mice show that lipid nanoparticle (LNP) formulations using ionizable lipid CP-LC-1254 exhibit comparable mRNA expression and favorable safety profiles compared to industry leading formulations in the industry. LNPs formulated with CP-LC-1254 have shown a primary biodistribution in the spleen and exhibit high endosomal escape.
C44H86N2O5S |